NEONC TECHNOLOGIES HOLDINGS, INC. Loans Payable, Current
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) had Loans Payable, Current of $11.38 million as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:LoansPayableCurrent · last filed 2026-03-31
- 2025-03-31: Loans Payable, Current $11.38M.
- 2024-12-31: Loans Payable, Current $11.75M; Loans Payable, Current as first filed $9.80M.
- 2024-06-30: Loans Payable, Current $11.75M.
- 2024-03-31: Loans Payable, Current $11.38M.
| Period end | Loans Payable, Current | Loans Payable, Current as first filed |
|---|---|---|
| 2025-03-31 | $11.38M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $11.75M 10-K · filed 2026-03-31 | $9.80M 10-Q · filed 2025-05-09 |
| 2024-06-30 | $11.75M 10-Q · filed 2025-08-18 | |
| 2024-03-31 | $11.38M 10-Q · filed 2025-08-18 | |
| 2023-12-31 | $9.80M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |